HomeNews

Photocure ASA: Share Option Program

Published: 4 April 2013
This information is subject of the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.

News and events

OSE Notice
Photocure and Richard Wolf Enter into Agreement to Develop a High-Definition Flexible Blue Light Cystoscope for Global Commercialization
Oslo, Norway
15 July 2024
NEWS POST
New Photocure White Paper: Beyond the buzzwords – How AI and advancing diagnostic technologies will transform early bladder cancer care
Oslo, Norway
19 June 2024
PRESS-RELEASE
Photocure Announces Mobile BLC Tower Initiative to Expand Access to Cysview in the U.S.
Oslo, Norway
4 June 2024
OSE Notice
Photocure ASA – Annual general meeting held
Oslo, Norway
23 May 2024
OSE Notice
Photocure ASA: Results for the first quarter of 2024
Oslo, Norway
15 May 2024
PRESS-RELEASE
Photocure Partner Asieris announces New Drug Application acceptance for regulatory review of Cevira in China
Oslo, Norway
12 May 2024
OSE Notice
Photocure ASA: Invitation to presentation of first quarter 2024 financial results
Oslo, Norway
8 May 2024
PRESS-RELEASE
Bladder Cancer: Long-Term Benefits of Blue Light Cystoscopy and Enhanced Detection with HD Technology Unveiled at AUA 2024
Oslo, Norway
7 May 2024
OSE Notice
Photocure ASA – Notice of the Annual General Meeting 23 May 2024
Oslo, Norway
30 April 2024
OSE Notice
Photocure ASA: Annual Report 2023
Oslo, Norway
30 April 2024
PRESS-RELEASE
Bladder Cancer: pivotal trial results and new real-world evidence, to be presented at AUA 2024, demonstrate improved diagnostic and clinical outcomes with blue light cystoscopy
Oslo, Norway
30 April 2024
OSE Notice
Photocure ASA – Share option grant
Oslo, Norway
25 April 2024
PRESS-RELEASE
European Association of Urology (EAU) 2024 congress features new data on modern technology use in bladder cancer care
Oslo, Norway
8 April 2024
PRESS-RELEASE
Photocure to Participate in the 23[rd] Annual Needham Virtual Healthcare Conference
Oslo, Norway
5 April 2024
NEWS POST
EAU 2024: Photocure Partner Asieris to present the Drug and Equipment Performance Results from the Chinese Phase III Clinical Study of Hexvix in Combination with HD 4K Blue Light Cystoscopy equipment
Oslo, Norway
1 April 2024
PRESS-RELEASE
New Publication: Racial Difference in Detection Rate of Bladder Cancer Using Blue Light Cystoscopy
Oslo, Norway
28 March 2024
GLOBAL HEADQUARTERS

Photocure ASA
Hoffsveien 4
0275 Oslo
Norway

E-mail: info@photocure.no
NORTH AMERICA

Photocure INC
202 Carnegie Center
Suite 101, Princeton,
NJ 08540, USA

E-mail: info@photocure.com
EUROPE

Photocure GmbH 
Breite Str. 27 
40213 Düsseldorf 
Germany

E-mail: kontakt@photocure.com
Follow us
Privacy PolicyTerms of use
© Photocure 2024